BioCentury
ARTICLE | Clinical News

VZIG antibody to the chickenpox virus: Phase III trial this month.

September 9, 1996 7:00 AM UTC

Cangene Corp. (TSE:CNJ), Mississauga, Ontario Product: VZIG antibody to the chickenpox virus (Varicella zoster) Indication: Prevent or decrease symptoms of chickenpox in women exposed while pregnant ...